Tissue Regenix
Tissue Regenix Group is a pioneering international medical technology company focused on developing regenerative products using platform technologies dCELL® and BioRinse™, which address soft tissue and bone allograft needs respectively. The company aims to transform patient care and deliver favorable health economic outcomes through innovation in regenerative medicine. With state-of-the-art facilities in the UK, US, and Germany, Tissue Regenix operates in key markets including BioSurgery, Orthopaedics, Dental, and others, emphasizing sustainability, innovation, and excellence in healthcare.
Industries
Nr. of Employees
medium (51-250)
Tissue Regenix
York, York, United Kingdom, Europe
Products
Decellularised soft tissue grafts
Biological soft-tissue scaffolds produced by decellularisation to reduce antigenicity and enable host cell repopulation for applications such as dermis, vascular patches and other soft-tissue repairs.
Sterile osteoinductive bone allograft matrices
Sterile bone graft materials processed to retain native osteoinductive factors and collagen handling properties for spinal, dental and orthopaedic applications.
Birth-tissue-derived membranes
Processed amnion-derived membranes intended for use as wound coverings and ocular applications to provide barrier function and support healing.
Xenograft and porcine-derived implantable devices
Porcine-derived implantable devices and xenograft products manufactured for surgical applications, with experience in obtaining market clearance and preparing for international launches.
Decellularised soft tissue grafts
Biological soft-tissue scaffolds produced by decellularisation to reduce antigenicity and enable host cell repopulation for applications such as dermis, vascular patches and other soft-tissue repairs.
Sterile osteoinductive bone allograft matrices
Sterile bone graft materials processed to retain native osteoinductive factors and collagen handling properties for spinal, dental and orthopaedic applications.
Birth-tissue-derived membranes
Processed amnion-derived membranes intended for use as wound coverings and ocular applications to provide barrier function and support healing.
Xenograft and porcine-derived implantable devices
Porcine-derived implantable devices and xenograft products manufactured for surgical applications, with experience in obtaining market clearance and preparing for international launches.
Services
Donor services and tissue recovery
Medical review, donor sourcing, chart release and tissue recovery services to supply donor material for processing or distribution.
Contract manufacturing and in‑house tissue processing
Manufacture and processing of porcine, xenograft and human tissue-based products at regulated facilities, including capacity expansion and manufacturing transfer services.
Regulatory, quality and validation support
Quality system implementation, regulatory affairs support, design verification and validation for tissue-derived and device-classified products.
Commercialisation, distribution and licensing services
Support for market entry, distributor management, GPO engagement and licensing for geographic expansion.
Donor services and tissue recovery
Medical review, donor sourcing, chart release and tissue recovery services to supply donor material for processing or distribution.
Contract manufacturing and in‑house tissue processing
Manufacture and processing of porcine, xenograft and human tissue-based products at regulated facilities, including capacity expansion and manufacturing transfer services.
Regulatory, quality and validation support
Quality system implementation, regulatory affairs support, design verification and validation for tissue-derived and device-classified products.
Commercialisation, distribution and licensing services
Support for market entry, distributor management, GPO engagement and licensing for geographic expansion.
Expertise Areas
- Regenerative medicine
- Decellularised tissue scaffolds
- Allograft bone processing and osteoinduction
- Tissue banking and donor services
Key Technologies
- Tissue decellularisation
- Osteoinductive allograft processing
- Biological scaffold fabrication
- Birth-tissue (amnion) membrane processing